Beam Therapeutics Inc. (BEAM) scores 46 out of 100 on boothcheck's 11-model valuation framework. Verdict: Avoid The estimated fair value is $6.39, representing a 73% premium to fair value. Quantitative score: 61/100. Qualitative score: 30/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.